Cargando…

Macrophage DCLK1 promotes atherosclerosis via binding to IKKβ and inducing inflammatory responses

Atherosclerosis is a chronic inflammatory disease with high morbidity and mortality rates worldwide. Doublecortin‐like kinase 1 (DCLK1), a microtubule‐associated protein kinase, is involved in neurogenesis and human cancers. However, the role of DCLK1 in atherosclerosis remains undefined. In this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Zhuqi, Shen, Sirui, Han, Xue, Li, Weixin, Luo, Wu, Lin, Liming, Xu, Mingjiang, Wang, Yi, Huang, Weijian, Wu, Gaojun, Liang, Guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165355/ https://www.ncbi.nlm.nih.gov/pubmed/36896602 http://dx.doi.org/10.15252/emmm.202217198

Ejemplares similares

Anti-inflammatory therapy of atherosclerosis: focusing on IKKβ
por: Gan, Jiali, et al.
Publicado: (2023)

Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis
por: Chen, Taiwei, et al.
Publicado: (2020)

IKKβ links vascular inflammation to obesity and atherosclerosis
por: Sui, Yipeng, et al.
Publicado: (2014)

Analysis of the clinical significance of DCLK1(+) colorectal cancer using novel monoclonal antibodies against DCLK1
por: Dai, Tianqi, et al.
Publicado: (2018)

DCLK1 autoinhibition and activation in tumorigenesis
por: Cheng, Linna, et al.
Publicado: (2021)

IKKβ/NF-κB and the miscreant macrophage
por: Timmer, Anjuli M., et al.
Publicado: (2008)

Macrophage DCLK1 promotes obesity-induced cardiomyopathy via activating RIP2/TAK1 signaling pathway
por: Yang, Bin, et al.
Publicado: (2023)

DCLK1 immunoreactivity in colorectal neoplasia
por: Gagliardi, Giuseppe, et al.
Publicado: (2012)

Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cells
por: Huang, Shushi, et al.
Publicado: (2021)

Correction for: Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cells
por: Huang, Shushi, et al.
Publicado: (2022)

An antiinflammatory role for IKKβ through the inhibition of “classical” macrophage activation
por: Fong, Carol Ho Yan, et al.
Publicado: (2008)

Structural Basis of Inhibition of DCLK1 by Ruxolitinib
por: Jang, Dong Man, et al.
Publicado: (2021)

Inflammatory related gene IKKα, IKKβ, IKKγ cooperates to determine liver cancer stem cells progression by altering telomere via heterochromatin protein 1-HOTAIR axis
por: An, Jiahui, et al.
Publicado: (2016)

Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors
por: Prescott, Jack A., et al.
Publicado: (2018)

An unexpected twist to the activation of IKKβ: TAK1 primes IKKβ for activation by autophosphorylation
por: Zhang, Jiazhen, et al.
Publicado: (2014)

XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression
por: Yang, Wei-Qiang, et al.
Publicado: (2021)

IKKα and IKKβ Regulation of DNA Damage-Induced Cleavage of Huntingtin
por: Khoshnan, Ali, et al.
Publicado: (2009)

Ainsliadimer A selectively inhibits IKKα/β by covalently binding a conserved cysteine
por: Dong, Ting, et al.
Publicado: (2015)

Crystal structure of inhibitor of κB kinase β (IKKβ)
por: Xu, Guozhou, et al.
Publicado: (2011)

Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma
por: Mieczkowski, Jakub, et al.
Publicado: (2015)

Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity
por: Ding, Ling, et al.
Publicado: (2021)

Evaluation of the IKKβ Binding of Indicaxanthin by Induced-Fit Docking, Binding Pose Metadynamics, and Molecular Dynamics
por: Allegra, Mario, et al.
Publicado: (2021)

Pleiotropic effects of DCLK1 in cancer and cancer stem cells
por: Chhetri, Dibyashree, et al.
Publicado: (2022)

Protein Engineering of the N-Terminus of NEMO: Structure Stabilization and Rescue of IKKβ Binding
por: Guo, Bingqian, et al.
Publicado: (2014)

Data on the mode of binding between avenanthramides and IKKβ domains in a docking model
por: Kang, Chounghun, et al.
Publicado: (2018)

The TBK1/IKKε inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis
por: Zhao, Peng, et al.
Publicado: (2022)

Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)
por: Xu, Zheng, et al.
Publicado: (2017)

Mapping the IκB Kinase β (IKKβ)-binding Interface of the B14 Protein, a Vaccinia Virus Inhibitor of IKKβ-mediated Activation of Nuclear Factor κB
por: Benfield, Camilla T. O., et al.
Publicado: (2011)

Context-Dependent Role of IKKβ in Cancer
por: Page, Angustias, et al.
Publicado: (2017)

The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin
por: Galvan, Laurie, et al.
Publicado: (2018)

DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma
por: Lorenzo, Nevi, et al.
Publicado: (2021)

DCLK1 Inhibition Sensitizes Colorectal Cancer Cells to Radiation Treatment
por: Mohammadi, Chiman, et al.
Publicado: (2021)

Mechanistic and evolutionary insights into isoform-specific ‘supercharging’ in DCLK family kinases
por: Venkat, Aarya, et al.
Publicado: (2023)

Structure-Guided Prediction of the Functional Impact of DCLK1 Mutations on Tumorigenesis
por: Carli, Annalisa L. E., et al.
Publicado: (2023)

Mechanistic and evolutionary insights into isoform-specific ‘supercharging’ in DCLK family kinases
por: Venkat, Aarya, et al.
Publicado: (2023)

Author Correction: Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)
por: Xu, Zheng, et al.
Publicado: (2021)

Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism
por: Sureban, Sripathi M., et al.
Publicado: (2015)

MicroRNA-223-5p suppresses the progression of nasopharyngeal carcinoma by targeting DCLK1
por: Zhang, Zhixuan, et al.
Publicado: (2021)

Co-localization of autophagy-related protein p62 with cancer stem cell marker dclk1 may hamper dclk1's elimination during colon cancer development and progression
por: Roy, Badal Chandra, et al.
Publicado: (2019)

Hit identification of IKKβ natural product inhibitor
por: Leung, Chung-Hang, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_99qn131ab85p3hb4cdg2c7h9mp